|
NOTCH2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.54280000003371E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.396400E-04 |
| Normal-vs-Stage2 |
1.125990E-02 |
| Normal-vs-Stage3 |
1.963030E-01 |
| Normal-vs-Stage4 |
4.401200E-01 |
| Stage1-vs-Stage2 |
7.294600E-01 |
| Stage1-vs-Stage3 |
7.398400E-01 |
| Stage1-vs-Stage4 |
6.146400E-01 |
| Stage2-vs-Stage3 |
6.265800E-01 |
| Stage2-vs-Stage4 |
4.383800E-01 |
| Stage3-vs-Stage4 |
8.258200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.68949999999057E-05 |
| Normal-vs-AfricanAmerican |
2.782000E-03 |
| Normal-vs-Asian |
9.332600E-01 |
| Caucasian-vs-AfricanAmerican |
5.799400E-01 |
| Caucasian-vs-Asian |
7.210300E-02 |
| AfricanAmerican-vs-Asian |
2.703400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.166910E-04 |
| Normal-vs-Female |
3.82939999999943E-05 |
| Male-vs-Female |
2.525900E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.382040E-01 |
| Normal-vs-Extreme_Weight |
5.837500E-03 |
| Normal-vs-Obese |
9.242200E-04 |
| Normal-vs-Extreme_Obese |
3.863800E-01 |
| Normal_Weight-vs-Extreme_Weight |
4.187000E-01 |
| Normal_Weight-vs-Obese |
8.123600E-02 |
| Normal_Weight-vs-Extreme_Obese |
9.017800E-01 |
| Extreme_Weight-vs-Obese |
2.807800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.797000E-01 |
| Obese-vs-Extreme_Obese |
1.209990E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.671600E-02 |
| Normal-vs-Age(41-60Yrs) |
1.00999999996798E-06 |
| Normal-vs-Age(61-80Yrs) |
6.018100E-03 |
| Normal-vs-Age(81-100Yrs) |
7.579800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.612200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.449360E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.033800E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.279300E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.116570E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.364000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.77809999946099E-07 |
| Normal-VS-Type2 PRCC |
7.693800E-01 |
| Normal-VS-KIRP CIMP |
6.643900E-02 |
| Normal-VS-Unclassified PRCC |
2.978900E-03 |
| Type1 PRCC-VS-Type2 PRCC |
1.79889999999405E-05 |
| Type1 PRCC-VS-KIRP CIMP |
2.401000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
6.262600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.209600E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
5.419000E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
3.100000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.970600E-01 |
| Normal-vs-N1 |
7.275700E-02 |
| Normal-vs-N2 |
3.988400E-01 |
| N0-vs-N1 |
1.566030E-01 |
| N0-vs-N2 |
4.908400E-01 |
| N1-vs-N2 |
9.693800E-01 |
|
|
